loading
Allarity Therapeutics Inc stock is traded at $1.1901, with a volume of 561.90K. It is down -9.11% in the last 24 hours and down -30.65% over the past month. Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
See More
Previous Close:
$1.32
Open:
$1.33
24h Volume:
561.90K
Relative Volume:
0.51
Market Cap:
$1.74M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00496
EPS:
-239.88
Net Cash Flow:
$-12.75M
1W Performance:
-13.06%
1M Performance:
-30.65%
6M Performance:
+87.76%
1Y Performance:
-88.47%
1-Day Range:
Value
$1.15
$1.3399
1-Week Range:
Value
$1.15
$1.53
52-Week Range:
Value
$0.1131
$22.20

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Name
Name
Allarity Therapeutics Inc
Name
Phone
401-426-4664
Name
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Name
Employee
6
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ALLR's Discussions on Twitter

Compare ALLR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ALLR 1.1966 1.74M 0 -11.90M -12.75M -239.88
VRTX 467.37 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.78 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 564.61 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.58 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.54 24.08B 3.30B -501.07M 1.03B 11.54

Allarity Therapeutics Inc Stock (ALLR) Latest News

pulisher
08:02 AM

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements - GlobeNewswire

08:02 AM
pulisher
08:00 AM

Allarity's Phase 2 Cancer Drug Shows Promise: Patients Exceed 14-Month Treatment | ALLR Stock News - StockTitan

08:00 AM
pulisher
Nov 14, 2024

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights - The Manila Times

Nov 14, 2024
pulisher
Nov 13, 2024

FINAL REMINDER ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Allarity Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit! - AccessWire

Nov 13, 2024
pulisher
Nov 12, 2024

DEADLINE ALERT for ALLR, and COIN: The Law Offices of Frank - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - Business Wire

Nov 12, 2024
pulisher
Nov 11, 2024

FINAL ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Allarity Therapeutics, Inc. Investors to Join the Class Action Lawsuit! - AccessWire

Nov 11, 2024
pulisher
Nov 09, 2024

ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire

Nov 09, 2024
pulisher
Nov 09, 2024

ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. - The Bakersfield Californian

Nov 09, 2024
pulisher
Nov 09, 2024

ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALLR - GlobeNewswire Inc.

Nov 09, 2024
pulisher
Nov 08, 2024

ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Nov 08, 2024
pulisher
Nov 08, 2024

ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Nov 08, 2024
pulisher
Nov 08, 2024

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR) - Business Wire

Nov 08, 2024
pulisher
Nov 08, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - PR Newswire

Nov 08, 2024
pulisher
Nov 07, 2024

ALLR Deadline: ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

ALLR FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit - cnhinews.com

Nov 07, 2024
pulisher
Nov 06, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - GlobeNewswire

Nov 06, 2024
pulisher
Nov 05, 2024

ALLARITY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm - ForexTV.com

Nov 05, 2024
pulisher
Nov 05, 2024

ALLARITY ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Lawsuit filed for Investors who lost money with shares of Allarity Therapeutics, Inc. (NASDAQ: ALLR) - openPR

Nov 05, 2024
pulisher
Nov 04, 2024

Glancy Prongay & Murray LLP Reminds Investors of Looming - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

DEADLINE ALERT for WBTN, GTLB, ALLR, and COIN: The Law - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Nov 04, 2024
pulisher
Nov 02, 2024

ALLR 截止日期通知:全球領先的律師事務所 ROSEN 鼓勵 Allarity Therapeutics, Inc. 投資者在證券集體訴訟的重要截止日期 11 月 12 日 之前聘請律師 - GlobeNewswire Inc.

Nov 02, 2024
pulisher
Nov 02, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allarity Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesALLR - PR Newswire

Nov 02, 2024
pulisher
Nov 02, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors - GlobeNewswire

Nov 02, 2024
pulisher
Nov 02, 2024

ALLR DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire

Nov 02, 2024
pulisher
Nov 02, 2024

Allr Deadline Notice: Rosen, A Global And Leading Law Firm, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – ALLR - Wahanariau

Nov 02, 2024
pulisher
Nov 02, 2024

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, I - GuruFocus.com

Nov 02, 2024
pulisher
Oct 30, 2024

Allarity Therapeutics stock hits 52-week low at $1.32 amid steep decline - Investing.com Australia

Oct 30, 2024
pulisher
Oct 30, 2024

Allarity Therapeutics stock hits 52-week low at $1.32 amid steep decline By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Oct 30, 2024
pulisher
Oct 29, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

ALLR FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Allarity Therapeutics, Inc. Investors: Please contact the - GlobeNewswire

Oct 29, 2024
pulisher
Oct 28, 2024

ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Oct 28, 2024

Allarity Therapeutics Inc Stock (ALLR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):